We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NIQ:NYSENIQ Global Intelligence plc Analysis

Data as of 2026-06-03 - not real-time

$8.43

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

NIQ trades at $8.43, comfortably above the identified support of $8.05 but well under its 20‑day SMA of $9.19, 50‑day SMA of $10.32, and 200‑day SMA of $13.74, indicating a short‑term bearish price bias. The RSI sits at 38, suggesting the stock is approaching oversold territory, while the MACD line has crossed above its signal, delivering a bullish signal despite the broader downtrend. Volatility is elevated at 81.7% over the past 30 days and the beta of 0.92 points to slightly lower market sensitivity, yet the recent decrease in volume adds a liquidity caution. On the valuation side, the forward P/E of 6.97 and a price‑to‑book of 2.72 are modest, and analysts project a median target of $14, implying roughly 76% upside potential. Material news highlights robust revenue and EBITDA growth, AI‑driven market positioning, and strategic partnerships with Ulta Beauty and Hisense, reinforcing a narrative of expanding market reach. However, lingering concerns about competitive pressure temper enthusiasm.
Overall, the stock presents an attractive entry point from a valuation perspective, buoyed by strong growth catalysts and a bullish technical signal, but investors should watch for continued volume weakness and the broader bearish trend before committing larger positions.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price is near support but below all major moving averages
  • Decreasing volume raises liquidity concerns
  • MACD bullish crossover offers a short‑term upside hint

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E of 6.97 and 76% upside to median target $14
  • Strategic partnerships expanding data insights in beauty and consumer electronics
  • AI‑driven product enhancements driving revenue momentum

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Undervalued relative to growth prospects and low forward valuation multiples
  • Sustained international expansion and data‑intelligence market tailwinds
  • Analyst consensus of "buy" with median target well above current price

Key Metrics & Analysis

Financial Health

P/E Ratio7.0
P/B Ratio2.7

Technical Analysis

TrendBearish
RSI38.3
Support$8.05
Resistance$11.24
MA 20$9.19
MA 50$10.32
MA 200$13.74
MACDBullish
VolumeDecreasing
Fear & Greed Index92.75

Valuation

Target Price$14.85
Upside/Downside76.11%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.92
Volatility81.72%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.